A biosensor calibration structure is provided that includes at least two electrode structures in which at least one of the electrode structures has a non-random nanopattern on the sensing surface which provides a different sensing surface area than at least one other electrode structure. The at least one other electrode structure may be non-patterned (i.e., flat) or have another non-random nanopattern on the sensing surface. A biological functionalization material such as, for example, glucose oxidase or glucose dehydrogenase, can be located on at least the sensing surface of each electrode structure. The biosensor calibration structure can be used within a biosensor calibration method.

A method for processing a neural measurement obtained in the presence of artifact, in order to detect whether a neural response is present in the neural measurement. A neural measurement is obtained from one or more sense electrodes. The neural measurement is correlated against a filter template, the filter template comprising at least three half cycles of an alternating waveform, amplitude modulated by a window. From an output of the correlating, it is determined whether a neural response is present in the neural measurement.

An insertion device including an insertion needle holder and a drive mechanism for linearly moving the insertion needle holder in a puncturing direction. The insertion needle holder also includes at least one actuating element for actuating a drive mechanism. The drive mechanism converts a driving motion of the actuating element, which extends transversely or opposite to the puncturing direction, into a puncturing motion of the insertion needle holder.

A system and method for representing quasi-periodic electrocardiography waveforms, wherein system employs a hybrid-coding scheme combining linear predictive coding techniques based upon Algebraic Code Excited Linear Prediction with a discrete wavelet transforms.

The invention discloses a compact implantable biosensor assembly and a biological information monitoring device containing the assembly. The lower part of the implanted sensing section and of the needled for implantation are sealed in a closed space formed by the barrier, the lower part of the enclosure and the lower part of the needle aid. The horizontal connection section of the implantable sensing electrode is embedded in the enclosure. The export electrode is used to connect with a transmitter. The implantable biosensor assembly is directly connected with the circuit board of the transmitter through the export electrode, whereby the structure is compact.

Provided are are conformable conductors and electrode arrays and related methods of their manufacture and use. The disclosed structures can be implanted into or placed outside of the body of a subject to record biosignals and/or to deliver electrical stimulation, in addition to other, non-biological applications for electrical and/or chemical sensing and stimulation. One can form a pattern an absorbent material (e.g., with a laser cutter), which is later infused with a conductive ink that can include, e.g., MXene materials, reduced graphene oxide (rGO), graphene/graphite, gold, platinum, or other metallic nanoparticles, carbon nanotubes, conductive polymers, or other conductive ink materials. The resulting electrode arrays can be compatible with magnetic resonance imaging (MRI or fMRI) and transcranial magnetic stimulation (TMS) modalities, and the disclosed process can rapidly produce electrodes at high yield.

A flexible sensor configured for use in a bladder is flexible and moveable from a first position in which it is configured to not be discharged from the bladder to a second position in which it is configured to be inserted into the bladder. A sensor insertion tool includes an over sheath, a push rod configured to be inserted into a first lumen of the over sheath. The flexible sensor is positioned in the first lumen of the over sheath, the push rod is then inserted partially into the over sheath behind the flexible sensor. The sensor insertion tool is then positioned at a location, such as the opening to the bladder, in which the sensor is to be deployed.

Method and system for providing continuous calibration of analyte sensors includes calibrating a first sensor, receiving data associated with detected analyte levels from the first sensor, and calibrating a second sensor based on a predetermined scaling factor and data associated with detected analyte levels from the first sensor, is disclosed.

A medical device system is configured to guide implantation of a pacing electrode for left bundle branch pacing. The system includes a medical device having a processor configured to receive at least one cardiac electrical signal, determine a feature of the cardiac electrical signal, compare the feature to left bundle branch signal criteria, and determine a left bundle branch signal in response to the feature meeting the left bundle branch signal criteria. The system includes a display unit configured to generate a user feedback signal indicating advancement of a pacing electrode into a left portion of a ventricular septum in response to the processor determining the left bundle branch signal.

The disclosed technology provides a system and a computer implemented method for crisis state detection and intervention of a person or group of persons, the method comprising: providing a computer system designed to detect and intervene non-normal, elevated crisis operating states; using one or more biometric sensors that ascertains a crisis state via physical, behavioral, or mental indicators; deducing, with computational hardware, the operational state of a user or users from one or more biometric sensors; and administering an immediate, dual intervention of a sensory form to de-escalate the crisis operating state of a person or group of persons.